Rocket Pharmaceuticals (RCKT) Other Gross PP&E Adjustments (2016 - 2025)
Rocket Pharmaceuticals (RCKT) has disclosed Other Gross PP&E Adjustments for 10 consecutive years, with -$7.9 million as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments fell 131.79% to -$7.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$7.9 million through Dec 2025, down 131.79% year-over-year, with the annual reading at -$7.9 million for FY2025, 131.79% down from the prior year.
- Other Gross PP&E Adjustments hit -$7.9 million in Q4 2025 for Rocket Pharmaceuticals, down from $14.6 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $46.6 million in Q2 2024 to a low of -$28.3 million in Q4 2022.
- Historically, Other Gross PP&E Adjustments has averaged $9.9 million across 5 years, with a median of $12.4 million in 2021.
- Biggest five-year swings in Other Gross PP&E Adjustments: tumbled 296.81% in 2022 and later soared 13150.0% in 2024.
- Year by year, Other Gross PP&E Adjustments stood at $14.4 million in 2021, then crashed by 296.81% to -$28.3 million in 2022, then surged by 30.1% to -$19.8 million in 2023, then skyrocketed by 225.3% to $24.8 million in 2024, then tumbled by 131.79% to -$7.9 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for RCKT at -$7.9 million in Q4 2025, $14.6 million in Q3 2025, and $43.8 million in Q2 2025.